N6-methyladenosine modification in cancer

In this cross-journal collection, we welcome a wide range of articles on the role of N6-methyladenosine in cancer including primary research articles, method-based articles, reviews, and perspectives. N6-methyladenosine (m6A) is a modified mRNA, methylated at the N6-position of adenosine, recently shown as one of the most modification of mRNA and playing an important role in stimulating tumor promotion and inhibiting tumor suppression. Thus, modification and abnormal levels of N6-Methyladenosine play an important role in cancer development and progression. For example, m6A plays a role in AML, breast cancer, ovarian cancer pancreatic and renal cell cancer. Nevertheless, our insight in the complex ways of the mechanisms of tumor-regulation is still very incomplete. The accompanying collection of articles represents key research in this area from the journals Oncogene, Oncogenesis, Cancer Cell International, and Journal of Cancer Research and Clinical Oncology. The editors welcome future submissions to expand this collection further.

Articles (40 in this collection)